CORE D: Informatics To optimally and efficiently support clinical and translational research, one must go beyond gathering data from researchers, and utilize the tools and expertise of modern informatics. The spectrum of needs, from those of a basic scientist to those of an outcomes-based clinical researcher requires a robust architecture of software, hardware, and information technology professionals to develop and maintain these tools. The cost of equipment, the rapid pace of technology development and the specialized expertise required to properly manage the informatics needs of the MSCP are not possible without high quality and efficient informatics services. It is therefore critical that this resource be well supported and integrated into the research mission of UPCI and the particular needs of the MSCP. The Informatics Core of the MSCP is composed of the following integrated services: 1) Clinical Trials Management Application (CTMA) - supports all clinical trials of the MSCP and UPCI with integration to the Cancer Registry, Tissue Banking Information Systems and Organ Specific Databases.; 2) Tissue Banking Information System - supporting pathologic annotation and inventory control of the biospecimen (tissue, blood, serum and body fluids) requests of UPCI researchers 3) Registry Information Services - supporting all of the clinical and outcomes annotation of patients in clinical trials and who contribute their cancer tissues to the tissue bank 4) Honest Broker Services - an important component for HIPAA compliant research information services 5) Storage, Archival and Network Services - support robust network and storage solution for tissue banking, imaging, genomic and proteomic data archiving. Three tier backup services (on-line, near-line & remote) are provided. 6) caBIG integration and data sharing - supporting caBIG tissue bank tools support, caArray for genomic data and a NCI caBIG compliant data sharing plan in coordination for all projects and cores of the MSCP. MSCP will be increasingly reliant on the provision of robust research information services, to more effectively support the translation of innovation from the laboratory to the bedside and to utilize critical clinical and outcomes data in the clinic to guide discovery at the bench. Dr. Becich, leader of this core, is also the Biomedical Informatics Core leader for the newly funded Clinical and Translational Science Institute at the University of Pittsburgh as well as the Cancer Informatics Core of the UPCI's Cancer Center Support Grant (CCSG). This additional level of integration with NIH Roadmap Initiatives and the UPCI is a key strength of the proposed Informatics Core D of the Skin Cancer SPORE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA121973-04
Application #
8329700
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
4
Fiscal Year
2011
Total Cost
$142,240
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Anderson, Alyce; Ferris, Laura K; Click, Benjamin et al. (2018) Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients. Dig Dis Sci 63:2729-2739
Zhang, Yi; Liu, Zuqiang; Hao, Xingxing et al. (2018) Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model. Cancer Immunol Immunother 67:353-366
Lemchak, David; Banerjee, Swati; Digambar, Shaunak S et al. (2018) Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome. Exp Dermatol 27:188-190
Matsumoto, Martha; Secrest, Aaron; Anderson, Alyce et al. (2018) Estimating the cost of skin cancer detection by dermatology providers in a large health care system. J Am Acad Dermatol 78:701-709.e1
Ma, Jing; Salamoun, Joseph; Wipf, Peter et al. (2018) Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential. Oncotarget 9:6042-6054
Santos, Patricia M; Butterfield, Lisa H (2018) Dendritic Cell-Based Cancer Vaccines. J Immunol 200:443-449
Li, Chunlei; Song, Baobao; Santos, Patricia M et al. (2018) Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells. Cell Immunol :
Retseck, Janet; Nasr, Alexis; Lin, Yan et al. (2018) Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma. J Transl Med 16:184
Velásquez, Celestino; Amako, Yutaka; Harold, Alexis et al. (2018) Characterization of a Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cell Line CVG-1. Front Microbiol 9:713
Butterfield, Lisa H (2018) The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review. Semin Cancer Biol 52:12-15

Showing the most recent 10 out of 209 publications